Top Machine Learning Companies in Denver & Boulder, CO (121)

Strong Revenue Growth: Results indicate broad-based top-line momentum, with operating revenue and recurring revenue both rising strongly year over year. Organic growth is also highlighted, showing that expansion is not solely acquisition-driven.

Market Expansion: Customer numbers increased and international markets, including the U.S., showed accelerated traction. Management outlook points to continued expansion through further investment in key regions.

Healthy Cash Flow: Free cash flow increased alongside growth in adjusted EBITDA. This suggests the business is scaling while continuing to generate solid cash.

Strong Revenue Growth: Revenue at the New Zealand entity rose to NZ$98.1m for the nine months to December 2025 versus NZ$71m for the prior 12-month period, and farms served reportedly increased from 2,000 to 3,500 alongside collars deployed growing from 500k to 1.5m. Feedback suggests headcount more than doubled within 12 months, indicating scaling operations to support demand.

Investor Backing & Capital Strength: A US$220 million Series E at a reported US$2 billion valuation and a prior US$1 billion valuation signal substantial capacity to fund expansion, product development, and market entry. Feedback suggests plans to hire 200+ roles and expand into the UK and Ireland, supported by this capital base.

Market Expansion: Operations reportedly extended rapidly in the United States with approximately 1,000 ranch customers and activity in more than half of US states. Feedback suggests international expansion plans into Europe and increased satellite-collar deployments are opening new, harder-to-serve markets.

Market Expansion: Public-sector documentation of pilots and contract milestones in Colorado, plus a LinkedIn-noted I‑5 deployment in California, point to expanding geographic activity. References to agency engagement in states like Washington and North Carolina further indicate broader market reach.

Strong Hiring & Retention: Active listings across electrical, embedded, software, and machine-learning roles, along with a new Denver headquarters and an 11–50 employee footprint, indicate ongoing team expansion. Built In’s listing of roughly two dozen employees and multiple open roles reinforces continued hiring momentum.

Product Line Growth: The company’s site describes applications spanning all‑electronic tolling, HOV/express‑lane occupancy verification, commercial back‑office systems, interim tolling, and speed enforcement, indicating a broadened offering. Such scope suggests multiple avenues to capture demand across transportation and safety use cases.

Strong Revenue Growth: Multi-year revenue expansion is independently recognized by Deloitte’s Technology Fast 500 and the Inc. 5000, indicating substantial business momentum. These signals align with reported year-over-year gains and suggest the company has scaled meaningfully beyond its early-stage footprint.

Market Expansion: Rising federal contract obligations across recent fiscal years and new awards from multiple defense agencies point to a broader footprint within U.S. government contracting. Facility enlargement and access to additional contracting vehicles further indicate capacity to pursue and execute more work.

Innovation-Driven Growth: Active government-funded R&D and a Phase III transition for tactical networking upgrades, along with work in high‑frequency communications and alternative PNT, show a pipeline that can fuel continued expansion. Planned integration of upgrades on military platforms and participation across Navy programs signal commercially relevant innovation rather than lab-bound research.

Investor Backing & Capital Strength: A $650 million Series D in April 2026 lifted total capital raised since 2022 to over $1 billion, with a reported $2.2 billion valuation. These resources are directed toward scaling manufacturing, missions, and hiring, signaling strong capacity to fund expansion.

Strong Hiring & Retention: Headcount moved from roughly 170 in April 2025 toward a stated goal of exceeding 500 by year-end 2026, with third-party estimates during 2026 supporting substantial growth. Hiring tied to facility buildout and a growing mission cadence indicates active team scaling across engineering and operations.

Market Expansion: Selections for additional U.S. Space Force programs in 2026—such as GHOST-R GEO reconnaissance, Kronos battle-management software, Andromeda, and space-based interceptors—indicate widening demand for Jackal spacecraft and Mosaic software. Manufacturing investment in Long Beach and a growing mission pipeline further point to increasing participation in national-security space.

Strong Revenue Growth: Quarterly revenue increased materially year over year in Q2 2026, and full-year 2025 sales also rose. The acceleration into 2026 alongside expanding user metrics signals momentum in top-line performance.

Healthy Cash Flow: Free cash flow turned positive and expanded meaningfully versus the prior year, alongside a large step-up in adjusted EBITDA. This points to improving cash generation and operating efficiency.

Diversified Revenue Streams: Subscriptions and other direct revenue grew much faster than advertising, with products like Snapchat+, Lens+, and Memories contributing significantly. This diversification reduces sole dependence on the ad cycle and broadens monetization levers.

Strong Revenue Growth: Revenue surpassed $1 billion in Q3 2026 for the first time, and annual revenue rose from about $2.1 billion in 2023 to $3.15 billion in 2025, with the first nine months of 2026 continuing to climb. This trajectory reflects momentum across multiple periods rather than a single-quarter spike.

Profitability: Net income and adjusted EPS increased faster than revenue in recent periods, and the net revenue margin improved year over year. These patterns point to expanding earnings alongside top-line growth.

Diversified Revenue Streams: Growth is broad-based across small-business and consumer lending, with both originations, receivables, and segment revenues rising in Q3 2026. The small-business portfolio represents a meaningful share of receivables and continues to scale.

Strong Revenue Growth: Revenue is surging, with fiscal 2026 reaching $133.19 billion and a record $54.23 billion in the fourth quarter, helped by AI-related demand, higher average selling prices, and strong bit shipment growth. Guidance near $61.5 billion for the next quarter indicates continued momentum.

Profitability: Profitability is expanding sharply, with fiscal 2026 net income at $84.97 billion and gross margin rising to roughly 81% for the year and about 87% in Q4. Higher average selling prices and strong data‑center demand are converting revenue growth into outsized earnings.

Future-Ready Strategy: Capacity expansion and multi‑year customer agreements are being ramped to meet sustained AI memory demand, including new fabrication plants and substantial forward commitments. Management also expects another record year, signaling confidence in the trajectory.

Strong Revenue Growth: Feedback suggests AKASA reports more than tenfold growth since mid-2024 and nearly sixfold year-over-year inpatient volume processed, indicating rapid commercial traction and usage expansion.

Market Expansion: Feedback suggests deployments have broadened across major U.S. health systems, with a footprint reportedly spanning roughly 500 hospitals and customers representing about 10% of U.S. inpatient discharges.

Investor Backing & Capital Strength: Feedback suggests AKASA has attracted substantial capital, with reported total funding around $200M+, providing resources to scale products and partnerships.

Strong Revenue Growth: Management reported substantially accelerated revenue growth in 2024 and being on track to exceed financial targets, although specific figures were not disclosed. This indicates positive commercial momentum in its first year operating independently.

Product Line Growth: Recent launches—including Accuris Thread, an AI Assistant, BOM Intelligence, new Engineering Intelligence tiers, and Accuris Connect—extend coverage from standards into requirements, AI research, and supply-chain workflows. These additions broaden the portfolio and create more avenues to serve existing and adjacent use cases.

Market Expansion: Company communications describe more than 1,000 employees across 20 countries, a new Denver headquarters, and expanded offices in the UK, India, Malaysia, and Japan. This signals a wider geographic presence and scaling operations.

Investor Backing & Capital Strength: Recent funding of over $150M at a higher valuation, alongside stated profitability and nine-figure ARR, signal a strong financial position. These resources enable continued product investment and enterprise go-to-market execution.

Product Line Growth: Multiple 2025 launches (Anaconda AI Platform and AI Catalyst) and the 2026 acquisition of Outerbounds expand the offering from package management into governed AI workflows and orchestration. This broadening of scope increases upsell potential across experimentation-to-production needs.

Strong Market Position & Advantage: Large-scale usage claims and broad enterprise penetration, combined with pre-integrations and co-marketing with major vendors, reinforce a leading position in Python-centric data-science distribution and governance. Inclusion in analyst coverage for notebook-based ML further underscores relevance beyond packaging.

Investor Backing & Capital Strength: Evidence indicates Strive secured a substantial 2025 financing combining equity and debt, signaling strong investor confidence and runway for scaling. Company and trade coverage describe deploying this capital to expand operations and technology.

Market Expansion: Company materials indicate rapid growth from a multi‑state footprint to nationwide reach with a larger patient panel and higher medical spend under management. Feedback suggests this expanded presence strengthens resilience across markets and segments.

Strategic Partnerships: Disclosures point to multi‑year, at‑risk arrangements with national payers, health systems, and nephrology groups, as well as participation in federal kidney models. These relationships indicate payer/provider trust and operational readiness for advanced risk.